Clinical Trials Browser

Completed × pertuzumab × Tumor-Agnostic × Clear all

NCT03498521 2025-11-19

CUPISCO

Phase 2 Completed

529 enrolled 16 charts

Neoplasms, Unknown Primary

NCT04551521 2025-01-08

CRAFT: The NCT-PMO-1602 Phase II Trial

Phase 2 Completed

Neoplasm Metastasis

NCT00027027 2015-07-27

Safety Study of rhuMAb 2C4 to Treat Advanced Solid Tumors

Phase 1 Completed

21 enrolled 17 charts

Neoplasms